Letters Unintended effects of statins

Yellow card reports add to data

BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c3697 (Published 13 July 2010) Cite this as: BMJ 2010;341:c3697
  1. Katherine Davidson, senior pharmacist1,
  2. Sheena Kerr, lead pharmacist2,
  3. Moira Kinnear, head of pharmacy education research and development 2,
  4. D Nicholas Bateman, professor in clinical toxicology3
  1. 1Royal Infirmary of Edinburgh, Edinburgh EH16 4SA
  2. 2Western General Hospital, Edinburgh EX4 2XU
  3. 3YCC Scotland, Royal Infirmary of Edinburgh
  1. nick.bateman{at}luht.scot.nhs.uk

    Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe